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ABSTRACT
Snakebite envenomation is a common scenario in southern India. Among the various causes of acquired thrombotic thrombocytopenic 
purpura (TTP), snake bite envenomation is very rarely reported. We present a rare case of a 51-year-old man with TTP following 
snakebite envenomation. He developed features of TTP including impaired neurological state, renal dysfunction, low platelets, fever, 
microangiopathic hemolytic anemia on day 5 following snakebite. He received 7 cycles of plasma exchange and showed remarkable 
improvement. We are presenting this case to create awareness regarding TTP following snakebite as it has a very significant implication 
on treatment and mortality.
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Snake bite envenomation is seen very commonly in India. As per WHO, India has an estimated 2.8 million snakebite cases cumulatively. Most of the patients 
are presented with either a neurotoxic or hematotoxic 
manifestations. Venom-induced consumptive coagulopathy 
(VICC)  and disseminated intravascular coagulation (DIC)  are 
common manifestations in the first 48 hours [1]. However, few 
patients go on to develop features suggestive of thrombotic 
thrombocytopenic purpura (TTP) which has to be aptly 
identified and will alter therapy [2]. We present a case report 
of a patient who presented with hematotoxic snake bite and 
went on to develop secondary TTP.
CASE HISTORY
A 51-year-old man with no known co-morbidities was presented 
with alleged history of snakebite on his left foot 2 days prior 
to admission to our hospital. Initially, he was taken to a nearby 
hospital where the whole blood clotting time was more than 
20 minutes for which he received 30 vials of antisnake venom 
(ASV). He was shifted to our hospital where he was found to be 
breathless with a saturation of 88% on oxygen, blood pressure of 
80/40mmHg, and deranged renal function. Fang marks associated 
with cellulitis was noted on the left foot. 
He was intubated in view worsening respiratory distress, 
started on noradrenaline at 2.5mcg/kg/hr and renal replacement 
therapy. In view of coagulopathy, he received fresh frozen 
plasma (FFP)  transfusion. Coagulopathy resolved in 24 hours 
of admission. He underwent debridement of the wound and was 
started on broad injection pipercillin tazobactam and clindamycin 
for suspected cellulitis of left foot. 
Laboratory workup showed low platelets (8000/mm3), 
activated prothrombin time of 31 seconds, International 
normalization ratio – 1.3, lactate dehydrogenase – 1851, and 
peripheral smear showed the presence of schistocytes. We also 
noted a decreasing trend in hemoglobin up to 6g/dl on day 4. 
He required multiple blood component  transfusions, despite 
which a fall in platelets and hemoglobin with high LDH was 
noted. He needed dialysis in view of non-resolving acute 
kidney injury. 
He was gradually weaned off inotropes and remained 
hemodynamically stable. However, his sensorium did not 
improve and was persistently restless and agitated. He underwent 
MRI brain and CSF analysis for the same which was normal. 
After multidisciplinary consult including a haematologist, a 
diagnosis of TTP was made and was started on plasma exchange 
on day 6. He received 7 cycles of plasma exchange. ADAMTS 
13 level was done which was inconclusive. There was a gradual 
improvement in platelet count (>100,000/mm3 by 7th cycle) and 
his neurological status improved. 
He underwent a tracheostomy in view of prolonged 
ventilation. He was gradually weaned off the ventilator. His 
sensorium improved and the response was appropriate. However, 
he continued to need dialysis. He was shifted to the ward, 
rehabilitation was continued, tracheostomy was decannulated, 
acute kidney injury (AKI) gradually resolved and was discharged 
home after a month of hospitalization. He was followed up in the 
hospital and is doing well. 
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DISCUSSION 
Coagulopathy following snake bite (viper) has been described 
as DIC and venom-induced consumption coagulopathy (VICC).
VICC is characterized by rapid onset coagulopathy within hours 
after the snake bite with elevated D-dimer levels, prolonged 
prothrombin time, and low fibrinogen levels which at times is 
associated with thrombocytopenia.[1] This resolves within 24 to 
48 hours. It is not associated with systemic micro-thrombi and 
end-organ failure [1].
Thrombotic microangiopathy (TMA) occurs in the subset 
of patients in snake bite envenomation with or without VICC. 
The proposed mechanism is venom or its vascular endothelial 
toxins may act as von Willebrand factor activators or vascular 
endothelial growth factor–type factors and initiate TMA by 
inducing endothelial damage. The role of ADAMTS-13, a 
von-Willebrand factor-cleaving protease in snake bite is 
unclear. Most of the reports of TMA, after snake bite, are 
from Sri Lanka and Australia. In many of the reports, there 
were features of DIC/VICC which later went on to develop 
TMA. Hence, it was not clear whether thrombocytopenia 
and microangiopathic haemolytic anemia (MAHA) occurred 
as a part of DIC [2]. Casamento et al presented two cases 
of TMA caused by envenomation of common tiger snake 
(Notechisscutatus). ADAMTS -13 levels were however 
normal in this report [3].
Syndromes suggestive of TTP-HUS spectrum has been 
reported in the literature with other venomous animal bites 
[4,5,6]. Ho et al.[7] report an interesting case of tiger snake. 
In this case, after an initial VICC, the patient had acute 
renal failure and a high LDH level with normal coagulation 
parameters. There was also MAHA that followed the resolution 
of VICC. The ADAMTS 13 levels, were normal. A case of 
TMA following Humped nose viper envenomation has been 
reported from Srilanka by Withana M et al [8]. ADAMTS- 
13 levels were not measured. Plasma exchange was done. T. 
Dineshkumar et al [9]. reported two cases of TMA from Tamil 
Nadu recently following viper envenomation. ADAMTS-13 
levels were not measured in both the patients due to logistic 
reasons.
Most of the Indian patients who developed AKI are victims 
of Russell’s viper and saw-scaled viper. Bites are characterized 
by local inflammation, blistering and tissue necrosis. Systemic 
envenoming may cause coagulopathy, acute kidney injury 
and death [2]. Thrombotic microangiopathy is an uncommon 
complication of snake envenomation.
Most cases of TTP are associated with a deficiency of 
the metalloproteinase ADAMTS 13, which is responsible for 
cleavage of unusually large von Willebrand factor multimers in 
plasma. Its deficiency results in accumulation of these multimers 
giving rise to platelet aggregation, microthrombi formation, and 
thrombotic microangiopathy [10]. Still, TTP can be observed 
in patients with normal ADAMTS 13 levels and proposed 
hypotheses for pathogenesis in these circumstances include 
endothelial injury, increased platelet aggregation and increased 
levels of plasminogen-activator inhibitor type 1 (PAI-1). While 
primary or congenital cases of TTP are associated with a reduced 
level of ADAMTS 13, certain secondary causes of TTP may have 
normal levels of the enzyme [11,12].
The clinical indication and efficacy of plasma exchange in snake 
bite envenomation are unclear. American society for Apheresis 
has placed the role of plasmapheresis in envenomation as Grade 
2C, Category 3 (weak recommendation, optimum apheresis 
therapy not established, the decision should be individualized) 
evidence [13,14]. In patients refractory to conventional therapy 
with anti-snake venom, plasma exchange can be considered. In 
addition to the removal of toxins, mediators of inflammatory and 
coagulopathic pathway invoked by snake toxins can be removed 
and may be lifesaving in severely ill patients. 
We noted coagulopathy in our patient initially, which lasted for 
48 hours and was associated with AKI suggesting VICC. There 
was a trend of low platelets, MAHA, rising LDH, worsening 
neurological state. We commenced him on plasma exchange and 
a gradual recovery was noted. However, the levels of ADAMTS 
-13 was normal in our patient as well. In our case, the patterns of 
onset of TTP is very similar to the above-reported cases with an 
initial VICC followed by TTP. 
CONCLUSION
We have presented this case in view of creating awareness and 
to consider TTP as a differential following snake bite as it has 
a significant impact on treatment modality. Despite the role of 
plasma exchange remaining unclear in patients with normal 
ADAMTS - 13 levels, it seemed to have therapeutic benefit in 
our patient. 
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